These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21056989)

  • 1. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression.
    Wu YH; Wu TC; Liao JW; Yeh KT; Chen CY; Lee H
    Cancer Res; 2010 Dec; 70(24):10422-32. PubMed ID: 21056989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
    Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
    Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
    Yeh KT; Wu YH; Lee MC; Wang L; Li CT; Chen CY; Lee H
    Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum group C gene expression is predominantly regulated by promoter hypermethylation and contributes to p53 mutation in lung cancers.
    Wu YH; Tsai Chang JH; Cheng YW; Wu TC; Chen CY; Lee H
    Oncogene; 2007 Jul; 26(33):4761-73. PubMed ID: 17325666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XPC epigenetic silence coupled with p53 alteration has a significant impact on bladder cancer outcome.
    Yang J; Xu Z; Li J; Zhang R; Zhang G; Ji H; Song B; Chen Z
    J Urol; 2010 Jul; 184(1):336-43. PubMed ID: 20488473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin transiently up-regulates hHR23 expression through enhanced translational efficiency in A549 adenocarcinoma cells.
    Shen YH; Chen BR; Cherng SH; Chueh PJ; Tan X; Lin YW; Lin JC; Chuang SM
    Toxicol Lett; 2011 Sep; 205(3):341-50. PubMed ID: 21742020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
    Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
    Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of xeroderma pigmentosum complementation group C protein predicts cisplatin resistance in lung adenocarcinoma patients.
    Lai TC; Chow KC; Fang HY; Cho HC; Chen CY; Lin TY; Chiang IP; Ho SP
    Oncol Rep; 2011 May; 25(5):1243-51. PubMed ID: 21327329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HHR23A, a human homolog of Saccharomyces cerevisiae Rad23, regulates xeroderma pigmentosum C protein and is required for nucleotide excision repair.
    Hsieh HC; Hsieh YH; Huang YH; Shen FC; Tsai HN; Tsai JH; Lai YT; Wang YT; Chuang WJ; Huang W
    Biochem Biophys Res Commun; 2005 Sep; 335(1):181-7. PubMed ID: 16105547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of matrix metalloproteinase 1 in dermal fibroblasts from DNA repair-deficient/cancer-prone xeroderma pigmentosum group C patients.
    Fréchet M; Warrick E; Vioux C; Chevallier O; Spatz A; Benhamou S; Sarasin A; Bernerd F; Magnaldo T
    Oncogene; 2008 Sep; 27(39):5223-32. PubMed ID: 18469853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
    Melis JP; Wijnhoven SW; Beems RB; Roodbergen M; van den Berg J; Moon H; Friedberg E; van der Horst GT; Hoeijmakers JH; Vijg J; van Steeg H
    Cancer Res; 2008 Mar; 68(5):1347-53. PubMed ID: 18316597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS; Wang YC; Tseng RC; Chang JW; Chen JT; Shih CM; Chen CY; Wang YC
    Clin Cancer Res; 2004 Jul; 10(14):4734-41. PubMed ID: 15269146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons.
    Wu MH; Hong TM; Cheng HW; Pan SH; Liang YR; Hong HC; Chiang WF; Wong TY; Shieh DB; Shiau AL; Jin YT; Chen YL
    Mol Cancer Res; 2009 Mar; 7(3):311-8. PubMed ID: 19276182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis.
    Shintani Y; Higashiyama S; Ohta M; Hirabayashi H; Yamamoto S; Yoshimasu T; Matsuda H; Matsuura N
    Cancer Res; 2004 Jun; 64(12):4190-6. PubMed ID: 15205330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis.
    Downing S; Bumak C; Nixdorf S; Ow K; Russell P; Jackson P
    Mol Carcinog; 2003 Nov; 38(3):130-40. PubMed ID: 14587098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
    Katiyar SK; Meeran SM; Katiyar N; Akhtar S
    Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant melanoma cells acquire resistance to DNA interstrand cross-linking chemotherapeutics by p53-triggered upregulation of DDB2/XPC-mediated DNA repair.
    Barckhausen C; Roos WP; Naumann SC; Kaina B
    Oncogene; 2014 Apr; 33(15):1964-74. PubMed ID: 23604128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of eukaryotic initiation factor 4E (eIF4E) and its clinical significance in lung adenocarcinoma.
    Wang R; Geng J; Wang JH; Chu XY; Geng HC; Chen LB
    Lung Cancer; 2009 Nov; 66(2):237-44. PubMed ID: 19261348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model.
    Nambiar PR; Giardina C; Guda K; Aizu W; Raja R; Rosenberg DW
    Cancer Res; 2002 Jul; 62(13):3667-74. PubMed ID: 12097273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.